Fortitude Family Office’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Buy
2,950
+928
+46% +$109K 0.07% 104
2026
Q1
$243K Buy
2,022
+349
+21% +$40.3K 0.05% 111
2025
Q4
$176K Sell
1,673
-78
-4% -$7.32K 0.04% 151
2025
Q3
$147K Sell
1,751
-118
-6% -$9.72K 0.04% 157
2025
Q2
$148K Sell
1,869
-1,553
-45% -$123K 0.05% 146
2025
Q1
$307K Sell
3,422
-751
-18% -$70.1K 0.11% 95
2024
Q4
$415K Buy
4,173
+376
+10% +$38.8K 0.15% 85
2024
Q3
$431K Buy
3,797
+2,271
+149% +$270K 0.17% 73
2024
Q2
$189K Buy
1,526
+781
+105% +$101K 0.11% 87
2024
Q1
$98.3K Hold
745
0.07% 98
2023
Q4
$81.2K Buy
+745
New +$77.3K 0.06% 114

Other funds holding MRK

Fortitude Family Office's MRK Position: Q2 2026 in Review

Fortitude Family Office increased its Merck (MRK) stake by 46% in Q2 2026, buying an estimated $109K and bringing the position to 2,950 shares worth $379K. The position accounts for 0.07% of the portfolio, ranked #104.

Fortitude Family Office first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $431K in Q3 2024. 1,588 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fortitude Family Office held 2,950 shares of Merck worth $379K as of Q2 2026.
  • Fortitude Family Office bought 928 Merck shares in Q2 2026, an estimated $109K.
  • Merck made up 0.07% of Fortitude Family Office's portfolio in Q2 2026, its #104 holding.
  • Fortitude Family Office first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Merck position peaked at $431K in Q3 2024.
  • 1,588 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.